search icon
search icon
Flag Arrow Down
Română
Română
Magyar
Magyar
English
English
Français
Français
Deutsch
Deutsch
Italiano
Italiano
Español
Español
Русский
Русский
日本語
日本語
中国人
中国人

Change Language

arrow down
  • Română
    Română
  • Magyar
    Magyar
  • English
    English
  • Français
    Français
  • Deutsch
    Deutsch
  • Italiano
    Italiano
  • Español
    Español
  • Русский
    Русский
  • 日本語
    日本語
  • 中国人
    中国人
Sections
  • News
  • Exclusive
  • INSCOP Surveys
  • Podcast
  • EU
  • Diaspora
  • Republic of Moldova
  • Politics
  • Economy
  • Current Affairs
  • International
  • Sport
  • Health
  • Education
  • IT&C knowledge
  • Arts & Lifestyle
  • Opinions
  • Elections 2025
  • Environment
About Us
Contact
Privacy policy
Terms and conditions
Quickly scroll through news digests and see how they are covered in different publications!
  • News
  • Exclusive
    • INSCOP Surveys
    • Podcast
    • EU
    • Diaspora
    • Republic of Moldova
    • Politics
    • Economy
    • Current Affairs
    • International
    • Sport
    • Health
    • Education
    • IT&C knowledge
    • Arts & Lifestyle
    • Opinions
    • Elections 2025
    • Environment
66 new news items in the last 24 hours
  1. Home
  2. Health

An experimental pill from AstraZeneca has shown a 56% reduction in the risk of breast cancer progression, according to a study presented at ASCO

Adrian Rusu
whatsapp
facebook
linkedin
x
copy-link copy-link
2 June 2025, 06:41
main event image
Health
Foto: pixabay.com/ro
google-preference

Always see our news on Google

Administration of AstraZeneca's experimental pill camizestrant to breast cancer patients at the first sign of resistance to standard therapies cut the risk of disease progression or death in half, according to results presented Sunday at the American Society of Clinical Oncology (ASCO) meeting in Chicago. 

Dr. Eleonora Teplinsky, an oncologist at Valley-Mount Sinai Comprehensive Cancer Care, said this early approach reduced the risk of disease progression or death by 56%.

Sources

sursa imagine
Stirile ProTV
Studiu: O pastilă experimentală reduce cu peste 50% riscul de progresie a cancerului de sân
sursa imagine
Stiripesurse
Veste-bombă de la AstraZeneca: dezvăluiri despre pastila ce va reduce la jumătate riscul de progresie a cancerului de sân
sursa imagine
News.ro
Un tratament al AstraZeneca cu o pastilă, bazat pe un test de sânge, reduce la jumătate riscul de progresie a cancerului de sân

Latest News

12:19

Over a million people evacuated in China due to Typhoon Dolphin

12:14

Mark Zuckerberg faces criticism after his superyacht, "Launchpad", did not intervene to help a stranded boat in Alaska

12:04

ITM Bucharest applies fines of 1.54 million lei for undeclared work

11:54

Pope Leo XIV sends a message to the youth at UNTOLD

11:45

Three teenagers, including a 16-year-old Romanian, pursued by police in Switzerland after being found in a stolen car.

See more news

NEWS ON THE SAME TOPICS

event image
International
AstraZeneca announced the failure of a drug for a rare heart condition, causing a 9% drop in the company's shares.
event image
International
AstraZeneca, negotiations with Bristol Myers Squibb for a possible merger that could create a 400 billion dollar group
event image
Health
An experimental injection against cancer completely eliminated tumors in patients who did not respond to chemotherapy or immunotherapy.
event image
Health
Cats could benefit from weight loss medications. The first tests are already underway.
event image
Health
WHO begins clinical study for an antiviral drug against Ebola
event image
Current Affairs
A study published by Science Daily analyzed nearly 500 tumors in cats and found genetic mutations similar to those encountered in humans, including in the case of breast cancer.
app preview
Personalized news feed, AI-powered search, and notifications in a more interactive experience.
app preview app preview
AstraZeneca experimental pill risk reduction breast cancer

Editor’s Recommendations

main event image
Opinions
4 hours ago
Editorials and opinions

Between political egos and the "Junk" abyss

main event image
Current Affairs
1 hour ago

New heatwave alerts in Romania: orange and yellow codes valid until Wednesday

Sources
imagine sursa
imagine sursa
imagine sursa
imagine sursa
main event image
Exclusive
3 hours ago
Original Content

August 10, 2026. TV: What was discussed last night on the news channels

main event image
Current Affairs
2 hours ago

Eight people have been arrested preventively after the stone and axe attack on an ambulance in Cluj County.

Sources
imagine sursa
imagine sursa
imagine sursa
imagine sursa
imagine sursa
+2
main event image
Current Affairs
4 hours ago

The Ministry of Finance launches a new edition of TEZAUR / Non-taxable interest rates of up to 7.15% per year

Sources
imagine sursa
imagine sursa
imagine sursa
imagine sursa
app preview
Personalized news feed, AI-powered search, and notifications in a more interactive experience.
app preview
app store badge google play badge
  • News
  • Exclusive
  • INSCOP Surveys
  • Podcast
  • EU
  • Diaspora
  • Republic of Moldova
  • Politics
  • Economy
  • Current Affairs
  • International
  • Sport
  • Health
  • Education
  • IT&C knowledge
  • Arts & Lifestyle
  • Opinions
  • Elections 2025
  • Environment
  • About Us
  • Contact
Privacy policy
Cookies Policy
Terms and conditions
Open source licenses
All rights reserved Strategic Media Team SRL

Technology in partnership with

anpc-sal anpc-sol